CRLBF logo

CRLBF
Cresco Labs Inc

7,492
Mkt Cap
$347.36M
Volume
468,958.00
52W High
$2.30
52W Low
$0.4256
PE Ratio
-2.55
CRLBF Fundamentals
Price
$0.9648
Prev Close
$0.919
Open
$0.875
50D MA
$1.00
Beta
1.15
Avg. Volume
1.09M
EPS (Annual)
-$0.3814
P/B
1.02
$835.05
Loading...
Loading...
News
all
press releases
Cannabis Operator GTBIF Stock Down 17% YTD: Should You Buy the Dip?
Green Thumb has lost 17% YTD as pricing pressure and competition weigh, but steady revenue growth and strong cash flow raise the question: Is the dip worth buying?
Zacks·16d ago
News Placeholder
More News
News Placeholder
Should Cresco Stock Be in Your Portfolio Post Q4 Earnings?
CRLBF faces US pricing pressure despite a Q4 sales beat and a strategic entry into Germany's cannabis market, raising questions about near-term upside.
Zacks·22d ago
News Placeholder
Cresco Labs Inc. (CRLBF) Reports Q4 Loss, Beats Revenue Estimates
Cresco Labs Inc. (CRLBF) delivered earnings and revenue surprises of +14.16% and +0.26%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·29d ago
News Placeholder
Cannabis Stock VRNO Rises 40% in a Year: Time to Buy, Sell or Hold?
Verano stock has surged more than 40% in a year amid U.S. marijuana rescheduling optimism, but revenue headwinds and rising competition may keep investors cautious.
Zacks·29d ago
News Placeholder
Perrigo (PRGO) Q4 Earnings Lag Estimates
Perrigo (PRGO) delivered earnings and revenue surprises of -3.75% and +0.72%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·1mo ago
News Placeholder
New Strong Sell Stocks for February 9th
GPRE, CRLBF and BSET have been added to the Zacks Rank #5 (Strong Sell) List on February 9, 2026.
Zacks·2mo ago
News Placeholder
Should You Buy GTBIF Stock After Marijuana Reclassification Order?
Shares of Green Thumb GTBIF jump nearly 35% on a marijuana rescheduling order, but pricing pressure and weak comps cloud the stock's near-term outlook.
Zacks·3mo ago
News Placeholder
Tilray Brands Strengthens Domestic Lead With Strong Q1 Cannabis Growth
TLRY posts a strong quarter as Canadian cannabis revenues grow and market shares climb across key product categories.
Zacks·4mo ago
News Placeholder
TLRY vs. CRLBF: Which Cannabis Player Offers Greater Upside?
Tilray Brands' global expansion and strong Canadian momentum spotlight its edge as investors weigh upside against Cresco Labs' slower growth.
Zacks·4mo ago
News Placeholder
Cresco Labs Expands Operations Beyond U.S.: How to Play the Stock?
CRLBF's move into Germany opens a new growth path as it navigates U.S. pricing pressure and rising competition in its core market.
Zacks·5mo ago
<
1
2
...
>

Latest CRLBF News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.